Howard Lim, University of Toronto

Research

Clinical Trial Gastroesophageal Cancer Her 2 Positive

Latest funding

A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
CIHR · 2022 · Principal investigator
$748,990
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
CIHR · 2022 · Principal investigator
$2,995,962
Canadian Cancer Rehabilitation (CanRehab) Team: Improving the systematic identification, management, and treatment of the adverse effects of cancer.
CIHR · 2019 · Co-investigator
$1,101,364

All 3 grants and awards

A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Elimova, Elena; Goodwin, Rachel A; Lim, Howard; O'Callaghan, Christopher J; Tu, Dongsheng

Keywords: Clinical Trial; Gastroesophageal Cancer; Her 2 Positive

$748,990

A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Elimova, Elena; Goodwin, Rachel A; Lim, Howard; O'Callaghan, Christopher J; Tu, Dongsheng

Keywords: Clinical Trial; Gastroesophageal Cancer; Her 2 Positive

$2,995,962

Canadian Cancer Rehabilitation (CanRehab) Team: Improving the systematic identification, management, and treatment of the adverse effects of cancer.

Co-investigatorCIHR2019Team Grant: CCS/CIHR Cancer Survivorship Team Grants

Principal investigators: Jones, Jennifer M

Keywords: Cancer; Clinical Trial; Feasibility; Implementation Science; Physical Function; Rehabilitation; Surveillance

$1,101,364

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2022

Subject: Prospective PhD student: Clinical Trial Dear Professor Lim, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on clinical trial connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]